Introduction
Antimicrobial resistance (AMR), is the potency of microbes to become resistant to
famous antibiotics.[1] AMR is an emerging global threat; it increases mortality and morbidity and strains
healthcare systems.[2] The current antimicrobial profile studies have proved that bacteria can cause infections
to become resistant to different groups of antibiotics, world health leaders have
described antibiotic-resistant microorganisms as “nightmare bacteria” that “pose a
catastrophic threat” to people.[3]
In the United States, according to the Center for Disease Control (CDC) in 2013, there
are about 23000 deaths a year as a result of infection with bacteria that are resistant
to known antibiotics, while about 2 million others develop an infection that is resistant
to antibiotics.[3] While, the CDC newly report in 2022 found that infections and deaths from drug-resistant,
hospital-acquired bacteria rose by 15% from 2019 to 2020, with alarming increases
in some of the most highly resistant bacterial pathogens.[4] The costs of introducing a new pharmaceutical product into clinical use are very
high, estimated at 1.7 billion $, according to the US department of health, which
is the highest estimate based on the 2020 data.[5]
In 2017, the World Health Organization (WHO) released a list of bacteria for which
new studies and medications were urgently required. High priority pathogens included
methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE), while critical priority pathogens included Acinetobacter baumannii, Pseudomonas aeruginosa, carbapenem-resistant Enterobacteriaceae, and Enterobacteriaceae that produce extended
spectrum beta-lactamases (ESBL).[6]
Gram-negative bacteria are more resistant than gram-positive bacteria because of their
unique structure, which also contributes to their widespread global burden of morbidity
and mortality.[7] The development of antimicrobial auxiliary agents, structural modification of existing
antibiotics, and research into and study of chemical structures with new mechanisms
of action and novel targets that resistant bacteria are sensitive to a few methods
that have been reported to combat and control resistant gram-negative bacteria.[7]
The antimicrobial resistance crisis in Libya has reached a point where the authorities
should work with other stakeholders to address it. The present review is highlighting
the situation of antimicrobial resistance and bacterial pathogenic profile in Libya.
Free-text web searches using PubMed, Google Scholar, and ResearchGate were searched
for articles on AMR published in English using the following keywords and MeSH terms
were used: “Antimicrobial Resistance and Libya,” “Antimicrobial Susceptibility and
Libya,” “Bacteria Diagnostic Libya,” “AMR/antibiotic and Libya,” and “AMR/antibiotic
prevalence and Libya.” These search keywords were entered in the above-mentioned searching
engine. Articles were retrieved if they were conducted in Libya and reported the proportion
of bacterial pathogens and AMR. Required data were extracted for the purpose of this
review report, and then further verified for identifying the prevalence and number
of susceptible and resistant pathogens in each source of infection.
Bacteria Resistance Pattern in Urinary Tract Infections.
Urinary tract infection (UTI) is one of the most common infections in routine clinical
practice, resulting in high rates of morbidity and high economic costs associated
with its treatment. It is the most common UTI and is responsible for 95% of all symptomatic
urinary tract infection. The risk of UTI in the female population is higher than that
in the male population although bacteria isolated from females were less resistant
than those isolated from males.[8]
Ghenghesh et al, 2003, reported that Escherichia coli was detected in 538 (24%) urine samples. Other bacteria detected were Staphylococcus in 8%, Proteus in 4%, Klebsiella spp., in 2%, Pseudomonas in 1%, and beta-hemolytic streptococci in 0.3%.[9] In the same study, antimicrobial susceptibility testing of 538 E. coli strains found 74% were resistant to ampicillin, 49% to cephaloridine, 25% to nitrofurantoin,
49% to tetracycline, and 45% to trimethoprim-sulphamethoxazole.[9]
When comparing these findings to the results of a study carried out in Tripoli, Libya
in 2017, shown that Staphylococci (64.5%), E. coli (29.0%), and Klebsiella pneumonia (6.5%) were the most often isolated bacteria from urine samples that had positive
culture results. Staphylococci spp. (26.29%), K. pneumonia and E. coli were much more resistant (38.11% and 34.13%, respectively) and showed resistance
to a wide variety of tested antibiotics. Gentamycin (17.6% resistance), erythromycin
(19.0% resistance), and ciprofloxacin were the three most potent antibiotics tested
that affected 87.7%, 82.4%, and 81.0% of the bacteria that cause urinary tract infections,
respectively.[10] Similarly, a study conducted in Sabha, Libya in 2007 reported that 178 (68.5%) of
urine samples were contaminated by E. coli with other micro-organisms. About 170 (65.4%) strains of E. coli were susceptible to nitrofurantoin, 157 (60.4%) to gentamicin, and 116 (44.6%) to
cephalexin. In contrast, only 6 (2.3%) of E. coli strains were sensitive to erythromycin and 14 (5.4%) to tetracycline.[11]
Another study investigated the resistance patterns of E. coli, Klebsiella spp., and S. aureus isolated from diabetic (DM) and non-diabetic patients to antimicrobial agents, revealed
that Klebsiella species from the non-DM group were significantly more resistant than isolates from
the DM group to co-amoxiclav acid [p = 0.002].[12] Moreover, S. aureus isolates from the non-DM group were resistant to methicillin. Additionally, E. coli, Klebsiella spp., and S. aureus exhibited 40%, 65%, and 29% multiple drug resistance profiles, respectively.[12]
Wareg et al, in 2014, revealed that vancomycin resistance was not found in in-patient-MRSA
strains while 5% of out-patient-MRSA strains were resistant by disc-diffusion assay.
This result suggests that vancomycin can be used to treat MRSA infections.[13] Another study on the detection of inducible clindamycin resistance to MRSA from
Libya reported 128 (24.2%) MRSA isolates collected were resistant to clindamycin,
63.2% of isolates were resistant to erythromycin.[14] The authors also emphasized that clindamycin could still be used to treat MRSA infection
in Libyan hospitals.[14]
In 2011, a study by Buzaid et al reported that of 200 S. aureus examined, 62 (31%) were MRSA. MRSA was found in 31.8% (28/88) and 30.4% (34/112)
of S. aureus in female and male patients. Based on the disc diffusion results, the pattern of
antibiotic resistance in 62 MRSA patients was as follows: 11 (17.7%) to vancomycin,
21 (33.9%) to ciprofloxacin, 24 (38.7%) to chloramphenicol, 26 (41.9%) to fusidic
acid, and 29 (46.8%) to erythromycin.[15]
Overall, E. coli accounted for most of UTI, and exhibited resistance to the common first-line regimes
such as nitrofurantoin and cotrimoxazole.
Bacterial Resistance Pattern in Respiratory Tract Infection.
Respiratory infections are one of the most common infectious diseases of various groups
that continue to emerge as major causes of clinical morbidity and mortality.[16] Upper respiratory tract infections (URTIs) involve the common cold, tonsillitis,
laryngitis, pharyngitis, rhinitis, and otitis media. Lower respiratory tract infections
(LRTIs) include acute bronchitis, and pneumonia.[17]
Previous study conducted by Elkammoshi in 2020 in Tripoli, Libya, in which 100 specimens
divided equally between ventilator circuits and lower respiratory tract patients were
analyzed. They found that the most common organism isolated was gram-negative from
the ventilators (26, 68.4%) and mechanically ventilated patients' LRT was 14 (70%).
Other isolates were gram-positive from patient's LRT were 6 (30%) and from ventilator
circuits were 12 (31.6%), and most of the isolates were resistant to the known antibiotics.[18] In the same study, A. baumannii showed a full resistance to amoxicillin, gentamycin, and the first generation of
cephalosporins, and it was intermediated to the third-generation cephalosporins. In
contrast, K. pneumoniae was also a fully resistant to gentamycin and most other types of antibiotics. Pseudomonas aeruginosa was also resistant to all types of antibiotics except gentamycin, to which it was
slightly sensitive. E. coli and Serratia marcescens were sensitive to most antibiotic disks except co-amoxiclav.[18]
Another study conducted by Atia in 2020 in Tripoli, showed the dominant bacterial
pathogens in respiratory infection being S. pneumonia 43.3%, followed by P. aeruginosa 22.8%, S. aureus 13.8%, E. coli 6.9%, Enterobacter spp. 6.2%, Citrobacter 4.5%, and Klebsiella 2.2%.[19]
It was observed that S. pneumonia was highly resistant to gentamycin and ciprofloxacin, whereas it was least resistant
to cefotaxime and doxycycline. Pseudomonas aeruginosa was resistant to β-lactam antibiotics such as co-amoxiclav, amoxicillin, ceftriaxone
as well as macrolide antibiotics such as clarithromycin with percent resistance of
71%, 44%, 29%, and 37%, respectively. P. aeruginosa was also resistant to ciprofloxacin, gentamicin, and amikacin with percentages of
24%, 24%. and 23%, respectively.[19]
Another study done by El-Deeb in 2006 in Libya showed that S. aureus was the most common organism, followed by Streptococcus pyogenes and K. pneumonia. Pseudomonas aeruginosa were represented, with S. marcescens and Morganella morganii being the least isolated organisms.[18] Levofloxacin and gatifloxacin, in the same study, showed the highest activity (100%),
followed by ofloxacin and ciprofloxacin (96.44% and 93.39%, respectively). Amoxicillin
and tetracycline were the least active (36.64% and 32.06%, respectively).[20]
The spectrum of pathogenic bacterium causing upper respiratory infection in Libya
is considerably wide, with S. pneumoniae and P. aeruginosa being the major causative bacteria.
Bacterial Resistance Pattern in Skin infections
Skin infections are a worldwide significant clinical concern characterized by microbial
attack of the skin layers and underlying soft tissues. Earlier study conducted in
Tripoli, Libya, showed that the dominated species of pathogenic bacteria were identified
as gram-positive bacteria S. aureus (n = 272, 97.14%) and Proteus (n = 8, 2.85%). Meanwhile, gram-negative bacteria were E. coli (n = 164, 93.71%), Pseudomonas (n = 8, 4.57%), Klebsiella (n = 2, 1.14%), and Shigella (n = 1, 0.57%). Of the gram-positive bacteria, S. aureus and Proteus were highly resistant to penicillin (34.3%, 75% respectively) and ampicillin (28.6%,
62.5%, respectively). Moreover, Proteus had lower resistance rate to sulfamethoxazole and nalidixic acid (12.5%). Concerning
gram-negative bacteria, E. coli was highly resistant to ampicillin (45.12%) and penicillin (35.96%), whereas the
lowest resistant was against imipenem (3.05%).[21]
Similarly, a study conducted in 2015 in Sabha showed that 90.5% of S. aureus strains were resistant to vancomycin, 61.9% to tetracycline, 57.1% to amoxicillin,
52.4% to methicillin, 42.9% to erythromycin, and 23.8% streptomycin. In addition,
87.5% of Staphylococcus epidermidis isolated was resistant to vancomycin, 75% to methicillin, 62.5% to tetracycline,
50% to streptomycin 37.5% to amoxicillin, and erythromycin.[22]
In another study conducted by Dou in a different area in Libya in 2011 showed that
Acinetobacter spp. was the most resistant pathogen. Most isolated gram-negative bacteria showed
great resistance to third-generation cephalosporins and aminoglycosides. However,
P. aeruginosa was quite susceptible to commonly used antipseudomonal therapy particularly carbapenems.
Coagulase-negative staphylococci were found to be sensitive to all the antibiotics
tested particularly gentamicin and vancomycin.[23]
Overall, S. aureus is stated to be among the most causative agent for skin infection, and shows high
resistance to penicillin groups of antibiotics.
Bacterial Resistance Pattern in Gynecological Infections
Bacterial vaginosis is a worldwide issue due to the raised risk of acquisition of
sexually transmitted infections. Bacterial vaginosis is a state that occurs when the
overgrowth of anaerobic bacteria. In some studies, however, other bacteria (E. coli, Klebsiella spp., Acinetobacter spp., Staphylococcus spp., enterococci, and S. agalactiae (group B streptococci) have been named “intermediate flora” or have been included
in other studies of bacterial vaginosis.[24] Previous study conducted in Tripoli, showed that E. coli was the most frequently isolated bacterium from vaginal swab, and showed resistance
to penicillin (62.5%), while the S. aureus and Streptococcus agalactiae were the dominant gram-positive bacteria showed high resistance to co-amoxiclav (40%).[24]
Bacterial Resistance Pattern in Other Infections
Methicillin-resistant staph (MRSA) and methicillin-susceptible staph (MSSA) are important
causes of infections in burn patients. A study conducted by Zorgani in Tripoli in
2012 showed that Tigecycline exhibited an excellent in vitro activity against MSSA and MRSA isolates (96.8% and 95.8%, respectively).[25]
Another study conducted by Al-awkally et al, in Tripoli 2020, aimed to assess the
antibiotic susceptibility of pseudomonas aeruginosa recovered from infected swabs,
abscess, burn, medical tips and blood, reported that P. aeruginosa was highly susceptible to Colistin and ciprofloxacin with some of the isolates shown
resistance to septrin, tetracycline, and levofloxacin.[26]
In a study conducted by Musa et al, in Misurata, Libya, found that the most common
bacteria isolated from anterior blepharitis were S. aureus 14 (25%) and S. epidermidis 14 (25%), and were resistant to vancomycin, gentamycin, ciprofloxacin, and amikacin.
In contrast, they were highly resistant to ampicillin and moderately resistant to
chloramphenicol, erythromycin, and cephalexin.[27]
Ermalli in 2017, collected 94 gram-negative bacteria isolates from different sources
at a single hospital in Tripoli, and reported different antimicrobial resistance phenotypes
including to the carbapenem classes. About 48% of the collection was identified as
A. baumannii, 50% K. pneumoniae, and 2% E. coli. Resistance to the carbapenem classes was reported in 96% of the A. baumannii strains and 94% of the K. pneumoniae strains. Approximately 78% of the isolates showed different multidrug-resistant (MDR)
phenotypes, of which K. pneumoniae expressing the highest rates of MDRs (i.e., 91%).[28]
